BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 24809891)

  • 1. Resident Rounds part III: scleromyxedema: a rare disorder associated with a monoclonal gammopathy.
    Mandell JA; Glick JB; Kaur RR
    J Drugs Dermatol; 2014 May; 13(5):619-20. PubMed ID: 24809891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Managing scleromyxedema with intravenous immunoglobulin: acute worsening of scleromyxedema with biclonal gammopathy.
    Manousaridis I; Loeser C; Goerdt S; Hassel JC
    Acta Dermatovenerol Alp Pannonica Adriat; 2010 Dec; 19(4):15-9. PubMed ID: 21390475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Scleromyxedema with an interstitial granulomatous-like pattern: a rare histologic variant mimicking granuloma annulare.
    Rongioletti F; Cozzani E; Parodi A
    J Cutan Pathol; 2010 Oct; 37(10):1084-7. PubMed ID: 19638067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Granulomatous scleromyxedema: case report and literature review.
    Shlyankevich J; Stetsenko GY; George E; Lantz DM; Burwick NR; Vary JC
    Am J Dermatopathol; 2015 Mar; 37(3):240-5. PubMed ID: 24247576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Scleromyxedema: clinical diagnosis and autopsy findings.
    Sala AC; Cunha PR; Pinto CA; Alves CA; Paiva IB; Araujo AP
    An Bras Dermatol; 2016; 91(5 suppl 1):48-50. PubMed ID: 28300892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Atypical papular mucinosis with initial histological findings evocative of granuloma annulare].
    de Cambourg G; Joganah N; Cribier B
    Ann Dermatol Venereol; 2012 Jan; 139(1):58-62. PubMed ID: 22225745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Response to thalidomide in scleromyxedema].
    Pascualini MF; Caballero Escuti G; Valente E; Kurpis M; Ruiz Lascano A
    Medicina (B Aires); 2013; 73(3):252-4. PubMed ID: 23732202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific lymph node involvement in scleromyxedema: a new diagnostic entity for hypermetabolic lymphadenopathy.
    Delyon J; Bézier M; Rybojad M; Brière J; Validire P; Bagot M; Janin A; Battistella M
    Virchows Arch; 2013 Jun; 462(6):679-83. PubMed ID: 23681113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Scleromyxedema and the dermato-neuro syndrome: case report and review of the literature.
    Fleming KE; Virmani D; Sutton E; Langley R; Corbin J; Pasternak S; Walsh NM
    J Cutan Pathol; 2012 May; 39(5):508-17. PubMed ID: 22515222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical characteristics, outcome of scleromyxoedema: a retrospective multicentre study].
    Le Moigne M; Mazereeuw-Hautier J; Bonnetblanc JM; Astudillo L; D'Incan M; Bessis D; Thomas L; Debarbieux S; Ammoury A; Lamant L; Paul C
    Ann Dermatol Venereol; 2010 Dec; 137(12):782-8. PubMed ID: 21134580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lichen myxedematosus: a rare group of cutaneous mucinosis.
    Cárdenas-Gonzalez RE; Ruelas MEH; Candiani JO
    An Bras Dermatol; 2019; 94(4):462-469. PubMed ID: 31644623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Scleromyxedema Without Monoclonal Gammopathy Treated with Intravenous Immunoglobulins.
    Letzelter M; Grimaux X
    Acta Dermatovenerol Croat; 2021 Apr; 291(1):51-53. PubMed ID: 34477065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Atypical scleromyxedema with a granulomatous histological pattern and delayed sclerosis].
    de Cambourg G; Goussot R; Wettlé C; Cribier B
    Ann Dermatol Venereol; 2016 May; 143(5):382-6. PubMed ID: 26969478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Scleromyxedema: An Atypical Case.
    Thomas E; George A; Deodhar D; John M
    Indian J Dermatol; 2015; 60(3):323. PubMed ID: 26120184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Scleromyxedema-like syndrome with systemic involvement in a cat.
    Müntener T; Rüfenacht S; Di Palma S; Hartmeier G; Welle M
    Vet Pathol; 2010 Mar; 47(2):346-50. PubMed ID: 20110223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discrete papular dermal mucinosis with Hashimoto thyroiditis: a case report.
    Ertam I; Karaca N; Ceylan C; Kazandi A; Alper S
    Cutis; 2011 Mar; 87(3):143-5. PubMed ID: 21488572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Scleromyxoedema with disseminated subcutaneous nodules: rare presentation of an uncommon dermatosis.
    Singh S; Kanwar AJ; Saikia UN
    Clin Exp Dermatol; 2013 Jan; 38(1):36-9. PubMed ID: 22607617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Scleromyxedema without paraproteinemia.
    Abarzúa AA; Giesen LF; Sandoval MO; González SB
    Int J Dermatol; 2014 Aug; 53(8):971-4. PubMed ID: 24527753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Scleromyxedema with multiple systemic involvement: Successful treatment with intravenous immunoglobulin.
    Kim S; Park TH; Lee SM; Kim YH; Cho MK; Whang KU; Kim HS
    Dermatol Ther; 2020 May; 33(3):e13378. PubMed ID: 32250023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Scleromyxedema histopathologically mimicking hypercellular fibrous papules (angiofibomas): Case report of an unusual histopathological presentation.
    Kazlouskaya V; Khan N; Heilman E
    J Cutan Pathol; 2020 Jul; 47(7):638-642. PubMed ID: 32048744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.